LHCG Stock Price
LHCG RSI Chart
LHCG Valuation
LHCG Price/Sales (Trailing)
LHCG Profitability
LHCG Fundamentals
LHCG Revenue
LHCG Earnings
Price Action
Last 7 days
2.5%
Last 30 days
3.2%
Last 90 days
1.1%
Trailing 12 Months
35.6%
LHCG Financial Health
LHCG Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for LHCG
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-02-22 | REED W EARL III | back to issuer | -5,100,000 | 170 | -30,000 | - |
2023-02-22 | Myers Keith G | back to issuer | -34,132,400 | 113 | -299,545 | ceo and chairman |
2023-02-22 | TURNER BRENT | back to issuer | -2,414,000 | 170 | -14,200 | - |
2023-02-22 | REED W EARL III | back to issuer | -4,734,160 | 170 | -27,848 | - |
2023-02-22 | Nixon Ronald T | back to issuer | -4,607,000 | 170 | -27,100 | - |
2023-02-22 | Seymour Kimberly S | back to issuer | -264,180 | 47.2172 | -5,595 | - |
2023-02-22 | Myers Keith G | back to issuer | -102,682,000 | 170 | -604,013 | ceo and chairman |
2023-02-22 | Proffitt Joshua L. | back to issuer | -7,809,290 | 66.4943 | -117,443 | president and coo |
2023-02-22 | Gachassin Nicholas III | back to issuer | -2,696,200 | 170 | -15,860 | evp, general counsel |
2023-02-22 | GOLDBERG JONATHAN | back to issuer | -311,100 | 170 | -1,830 | - |
Which funds bought or sold LHCG recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-08-22 | COMERICA BANK | sold off | - | - | - | -% |
2023-08-10 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | sold off | - | - | - | -% |
2023-07-14 | Laurus Investment Counsel Inc. | sold off | -100 | -2,925,960 | - | -% |
2023-07-14 | Ronald Blue Trust, Inc. | sold off | -100 | -21,000 | - | -% |
2023-05-11 | RAMIUS ADVISORS LLC | sold off | -100 | -2,134,310 | - | -% |
2023-04-24 | Ahrens Investment Partners LLC | sold off | -100 | -11,251,500 | - | -% |
2023-04-13 | Householder Group Estate & Retirement Specialist, LLC | sold off | -100 | -2,000 | - | -% |
2023-02-06 | Brinker Capital Investments, LLC | reduced | -3.05 | -172,413 | 3,917,590 | 0.08% |
2023-01-26 | Regent Investment Management LLC | unchanged | - | -3,000 | 296,000 | 0.08% |
2022-11-14 | SARISSA CONSULTING LLC | new | - | 1,637,000 | 1,637,000 | 1.69% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Schedule 13G FIlings of LHC Group
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 10, 2023 | blackrock inc. | 14.9% | 4,625,583 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 9.41% | 2,919,047 | SC 13G/A | |
| Jan 26, 2023 | blackrock inc. | 14.9% | 4,616,338 | SC 13G/A | |
| Jan 20, 2023 | blackrock inc. | 14.9% | 4,616,338 | SC 13G | |
| Jul 11, 2022 | wellington management group llp | 1.56% | 484,418 | SC 13G/A | |
| Feb 04, 2022 | wellington management group llp | 6.81% | 2,155,934 | SC 13G/A | |
| Jan 28, 2022 | blackrock inc. | 16.5% | 5,235,392 | SC 13G/A | |
| Apr 12, 2021 | wellington management group llp | 10.31% | 3,256,069 | SC 13G/A | |
| Feb 10, 2021 | vanguard group inc | 9.42% | 2,975,043 | SC 13G/A | |
| Feb 08, 2021 | fmr llc | - | 0 | SC 13G/A |
Peers (Alternatives to LHC Group)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
HCA | 68.9B | 61.9B | -8.98% | 30.00% | 11.93 | 1.11 | 3.02% | -11.37% |
LH | 18.2B | 14.1B | -4.55% | -3.42% | 21.91 | 1.29 | -5.68% | -58.27% |
DGX | 13.8B | 9.5B | -7.45% | 1.06% | 17.42 | 1.46 | -10.34% | -46.50% |
| MID-CAP | ||||||||
UHS | 8.9B | 13.8B | -2.67% | 35.75% | 12.86 | 0.65 | 5.76% | -10.75% |
CHE | 7.7B | 2.2B | 1.81% | 12.08% | 34.03 | 3.52 | 2.13% | -18.31% |
ENSG | 5.3B | 3.4B | -4.06% | 11.40% | 21.87 | 1.55 | 20.66% | 17.86% |
LHCG | 5.2B | 2.3B | 3.17% | 35.63% | 86.23 | 2.28 | 2.85% | -58.05% |
AMN | 3.1B | 4.4B | -6.99% | -20.79% | 9.81 | 0.71 | -16.06% | -30.43% |
AMED | 3.1B | 2.2B | 0.90% | -12.88% | 1.3K | 1.37 | 0.61% | -98.34% |
GH | 3.1B | 510.2M | -32.21% | -47.96% | -6 | 5.98 | 25.00% | 4.56% |
| SMALL-CAP | ||||||||
RDNT | 1.9B | 1.5B | -12.60% | 56.43% | -144.8 | 1.22 | 12.20% | -155.34% |
ADUS | 1.4B | 999.1M | -5.28% | -6.03% | 25.82 | 1.39 | 10.42% | 21.37% |
NHC | 1.0B | 1.1B | -3.25% | -4.64% | 32.02 | 0.93 | -2.07% | 1.61% |
VMD | 274.6M | 156.1M | -11.07% | 27.00% | 37.41 | 1.76 | 23.12% | -14.70% |
LHC Group News
Returns for LHCG
Cumulative Returns on LHCG
23.5%
10-Year Cumulative Returns
24.9%
7-Year Cumulative Returns
21.8%
5-Year Cumulative Returns
3.1%
3-Year Cumulative Returns
Risks for LHCG
What is the probability of a big loss on LHCG?
53.5%
Probability that LHC Group stock will be more than 20% underwater in next one year
19.6%
Probability that LHC Group stock will be more than 30% underwater in next one year.
14.2%
Probability that LHC Group stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does LHCG drawdown profile look like?
Y-axis is the maximum loss one would have experienced if LHC Group was unfortunately bought at previous high price.
Drawdowns
Financials for LHC Group
Income Statement (Last 12 Months)(In Millions)
| Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 |
| Revenue | -1.1% | 2,283 | 2,308 | 2,297 | 2,266 | 2,220 | 2,169 | 2,134 | 2,075 | 2,063 | 2,062 | 2,060 | 2,091 | 2,080 | 2,059 | 2,037 | 2,021 | 1,810 | 1,591 | 1,354 | 1,109 | 1,063 |
| Gross Profit | -0.9% | 884 | 891 | 884 | 890 | 883 | 879 | 883 | 836 | 813 | 786 | 754 | 765 | 755 | 753 | 744 | 733 | 654 | 572 | 484 | 399 | 387 |
| S&GA Expenses | 0.6% | 764 | 759 | 747 | 718 | 696 | 670 | 655 | 638 | 633 | 625 | 611 | 609 | 596 | 588 | 590 | 591 | 538 | 480 | 406 | 331 | 311 |
| EBITDA | -12.9% | 132 | 151 | 158 | 192 | 207 | 228 | 202 | 217 | 199 | 181 | 207 | 175 | 170 | 171 | - | - | - | - | - | - | - |
| EBITDA Margin | -12.0% | 0.06* | 0.07* | 0.07* | 0.08* | 0.09* | 0.11* | 0.09* | 0.10* | 0.10* | 0.09* | 0.10* | 0.08* | 0.08* | 0.08* | - | - | - | - | - | - | - |
| Interest Expenses | 39.6% | 31.00 | 22.00 | 15.00 | 8.00 | 4.00 | 2.00 | 1.00 | 2.00 | 4.00 | 7.00 | 9.00 | 11.00 | 11.00 | 10.00 | 11.00 | 11.00 | 10.00 | 9.00 | 6.00 | 4.00 | 3.00 |
| Earnings Before Taxes | -26.7% | 77.00 | 105 | 120 | 162 | 181 | 206 | 181 | 194 | 174 | 153 | 178 | 144 | 140 | 143 | 131 | 119 | 101 | 80.00 | 69.00 | 63.00 | 71.00 |
| EBT Margin | -25.9% | 0.03* | 0.05* | 0.05* | 0.07* | 0.08* | 0.09* | 0.08* | 0.09* | 0.08* | 0.07* | 0.09* | 0.07* | 0.07* | 0.07* | - | - | - | - | - | - | - |
| Net Income | -27.8% | 60.00 | 84.00 | 95.00 | 127 | 144 | 152 | 133 | 144 | 130 | 122 | 137 | 105 | 96.00 | 94.00 | 86.00 | 77.00 | 64.00 | 61.00 | 51.00 | 46.00 | 50.00 |
| Net Income Margin | -27.1% | 0.03* | 0.04* | 0.04* | 0.06* | 0.06* | 0.07* | 0.06* | 0.07* | 0.06* | 0.06* | 0.07* | 0.05* | 0.05* | 0.05* | - | - | - | - | - | - | - |
| Free Cashflow | 149.0% | 30.00 | -62.18 | -119 | -244 | -133 | -16.29 | 41.00 | 541 | 463 | 412 | 441 | 30.00 | 97.00 | 98.00 | - | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 |
| Assets | -0.6% | 2,897 | 2,914 | 2,938 | 2,944 | 2,896 | 2,713 | 2,367 | 2,523 | 2,483 | 2,456 | 2,357 | 2,212 | 2,140 | 2,098 | 2,030 | 2,014 | 1,929 | 1,911 | 1,882 | 805 | 794 |
| Current Assets | -7.3% | 408 | 440 | 460 | 485 | 433 | 452 | 510 | 684 | 647 | 656 | 565 | 439 | 380 | 373 | 358 | 366 | 367 | 367 | 350 | 208 | 201 |
| Cash Equivalents | 70.2% | 18.00 | 11.00 | 27.00 | 8.00 | 10.00 | 30.00 | 112 | 292 | 287 | 254 | 173 | 8.00 | 32.00 | 29.00 | 27.00 | 39.00 | 49.00 | 57.00 | 15.00 | 9.00 | 3.00 |
| Net PPE | 0.3% | 154 | 154 | 156 | 157 | 154 | 151 | 145 | 140 | 138 | 132 | 123 | 108 | 98.00 | 84.00 | 80.00 | 83.00 | 80.00 | 66.00 | 65.00 | 46.00 | 46.00 |
| Goodwill | 0.9% | 1,766 | 1,750 | 1,751 | 1,748 | 1,748 | 1,603 | 1,260 | 1,259 | 1,259 | 1,235 | 1,234 | 1,234 | 1,220 | 1,216 | 1,188 | 1,165 | 1,162 | 1,152 | 1,119 | 762 | 393 |
| Liabilities | -1.7% | 1,192 | 1,212 | 1,258 | 1,278 | 1,226 | 979 | 664 | 860 | 851 | 868 | 777 | 687 | 618 | 600 | 566 | 583 | 490 | 499 | 500 | 277 | 274 |
| Current Liabilities | -4.1% | 290 | 303 | 335 | 343 | 409 | 441 | 490 | 702 | 681 | 662 | 583 | 252 | 231 | 244 | 225 | 234 | 206 | 229 | 220 | 126 | 102 |
| LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.00 | 13.00 | 13.00 | 0.00 | 0.00 |
| LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Shareholder's Equity | -0.3% | 1,595 | 1,600 | 1,662 | 1,648 | 1,566 | 1,716 | 1,685 | 1,645 | 1,613 | 1,572 | 1,558 | 1,506 | 1,507 | 1,482 | 1,448 | 1,416 | 1,424 | 1,397 | 1,364 | 515 | 507 |
| Retained Earnings | -0.9% | 791 | 798 | 781 | 770 | 751 | 735 | 708 | 670 | 635 | 605 | 590 | 546 | 524 | 502 | 472 | 447 | 428 | 407 | 386 | 369 | 364 |
| Additional Paid-In Capital | 0.3% | 1,000 | 997 | 990 | 985 | 980 | 975 | 970 | 966 | 962 | 958 | 955 | 951 | 949 | 946 | 942 | 940 | 938 | 935 | 924 | 126 | 126 |
| Accumulated Depreciation | 3.5% | 114 | 111 | 107 | 102 | 98.00 | 94.00 | 91.00 | 87.00 | 83.00 | 79.00 | 74.00 | 74.00 | 69.00 | 66.00 | 62.00 | 59.00 | 55.00 | 53.00 | 49.00 | 46.00 | 44.00 |
| Shares Outstanding | 0.0% | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 30.00 | 18.00 | 18.00 |
| Minority Interest | - | - | - | - | - | - | - | - | - | - | 77.00 | 81.00 | 76.00 | 94.00 | 93.00 | 92.00 | 85.00 | 108 | 103 | 101 | 65.00 | 58.00 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 |
| Cashflow From Operations | 229.2% | 50.00 | -38.68 | -90.80 | -210 | -100 | 22.00 | 82.00 | 599 | 529 | 481 | 508 | 75.00 | 130 | 127 | 137 | 106 | 109 | 57.00 | 19.00 | 32.00 | 32.00 |
| Share Based Compensation | 3.0% | 20.00 | 19.00 | 18.00 | 17.00 | 16.00 | 15.00 | 15.00 | 14.00 | 14.00 | 14.00 | 12.00 | 12.00 | 10.00 | 8.00 | 10.00 | 10.00 | 9.00 | 9.00 | 7.00 | 6.00 | 6.00 |
| Cashflow From Investing | 74.4% | -58.36 | -227 | -611 | -609 | -607 | -452 | -76.51 | -77.88 | -82.50 | -80.15 | -110 | -112 | -107 | -84.99 | -52.65 | -24.18 | -25.29 | -15.40 | -46.88 | -72.64 | -74.77 |
| Cashflow From Financing | -93.3% | 16.00 | 247 | 618 | 535 | 431 | 207 | -65.68 | -236 | -191 | -176 | -251 | 8.00 | -40.25 | -69.72 | -73.20 | -52.82 | -36.78 | -1.51 | 36.00 | 34.00 | 42.00 |
| Buy Backs | -68.3% | 35.00 | 109 | 109 | 100 | 75.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LHCG Income Statement
2022-12-31CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands | 12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
| Income Statement [Abstract] | |||
| Net service revenue | $ 2,282,771 | $ 2,219,622 | $ 2,063,204 |
| Cost of service revenue (excluding depreciation and amortization) | 1,399,158 | 1,336,609 | 1,250,403 |
| Gross margin | 883,613 | 883,013 | 812,801 |
| General and administrative expenses | 764,239 | 696,435 | 632,847 |
| Impairment of intangibles and other | 10,854 | 937 | 1,849 |
| Operating income | 108,520 | 185,641 | 178,105 |
| Interest expense | (31,311) | (4,338) | (4,129) |
| Income before income taxes and noncontrolling interests | 77,209 | 181,303 | 173,976 |
| Income tax expense | 16,961 | 37,687 | 36,043 |
| Net income | 60,248 | 143,616 | 137,933 |
| Less net income attributable to noncontrolling interests | 20,377 | 27,888 | 26,337 |
| Net income attributable to LHC Group, Inc.’s common stockholders | $ 39,871 | $ 115,728 | $ 111,596 |
| Earnings per share - basic: | |||
| Net income attributable to LHC Group, Inc.’s common stockholders (in dollars per share) | $ 1.31 | $ 3.71 | $ 3.59 |
| Earnings per share - diluted: | |||
| Net income attributable to LHC Group, Inc.’s common stockholders (in dollars per share) | $ 1.30 | $ 3.69 | $ 3.56 |
| Weighted average shares outstanding: | |||
| Basic (in shares) | 30,539,343 | 31,195,305 | 31,092,417 |
| Diluted (in shares) | 30,659,727 | 31,396,658 | 31,365,765 |
| Cost, product and service [Extensible Enumeration] | Service [Member] | Service [Member] | Service [Member] |
| Revenue, product and service [Extensible Enumeration] | Service [Member] | Service [Member] | Service [Member] |
LHCG Balance Sheet
2022-12-31CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
|---|---|---|
| Current assets: | ||
| Cash | $ 17,911 | $ 9,809 |
| Receivables: | ||
| Patient accounts receivable | 313,163 | 348,820 |
| Other receivables | 13,506 | 13,780 |
| Total receivables | 326,669 | 362,600 |
| Prepaid income taxes | 17,120 | 7,531 |
| Prepaid expenses | 26,536 | 28,401 |
| Other current assets | 19,943 | 24,801 |
| Total current assets | 408,179 | 433,142 |
| Property, building and equipment, net of accumulated depreciation of $114,427 and $98,394, respectively | 154,283 | 153,959 |
| Goodwill | 1,765,778 | 1,748,426 |
| Intangible assets, net of accumulated amortization of $23,726 and $19,152, respectively | 395,328 | 400,002 |
| Operating lease right of use asset | 107,993 | 113,399 |
| Other assets | 65,396 | 46,693 |
| Total assets | 2,896,957 | 2,895,621 |
| Current liabilities: | ||
| Accounts payable and other accrued liabilities | 114,986 | 98,118 |
| Salaries, wages and benefits payable | 97,968 | 100,532 |
| Self insurance reserves | 37,348 | 33,784 |
| Contract liabilities - deferred revenue | 0 | 106,489 |
| Current operating lease payable | 36,445 | 37,630 |
| Amounts due to governmental entities | 3,707 | 5,447 |
| Current liabilities - deferred employer payroll tax | 0 | 26,790 |
| Total current liabilities | 290,454 | 408,790 |
| Deferred income taxes | 86,330 | 70,026 |
| Income taxes payable | 7,219 | 7,320 |
| Revolving credit facility | 733,000 | |
| Operating lease payable | 74,520 | 78,688 |
| Total liabilities | 1,191,523 | 1,226,021 |
| Noncontrolling interest-redeemable | 25,075 | 17,501 |
| Commitments and contingencies | ||
| LHC Group, Inc. stockholders’ equity: | ||
| Preferred stock – $0.01 par value: 5,000,000 shares authorized; none issued or outstanding | 0 | 0 |
| Common stock – $0.01 par value: 60,000,000 shares authorized; 36,744,210 and 36,549,524 shares issued, and 30,595,381 and 30,634,414 shares outstanding, respectively | 367 | 365 |
| Treasury stock – 6,148,829 and 5,915,110 shares at cost, respectively | (195,906) | (164,790) |
| Additional paid-in capital | 1,000,036 | 979,642 |
| Retained earnings | 790,896 | 751,025 |
| Total LHC Group, Inc. stockholders’ equity | 1,595,393 | 1,566,242 |
| Noncontrolling interest – non-redeemable | 84,966 | 85,857 |
| Total stockholders’ equity | 1,680,359 | 1,652,099 |
| Total liabilities and stockholders’ equity | $ 2,896,957 | $ 2,895,621 |
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI). The Home Health Services segment offers skilled nursing, medically oriented social services and physical, occupational, and speech therapy. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. Its Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand. The Facility-Based Services segment treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel. This segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The HCI segment provides strategic health management services to accountable care organizations. As of December 31, 2021, it operated 557 home health services locations, 170 hospice locations, 136 community-based service locations, 11 long-term acute care hospitals with 12 locations, and 14 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.